Loading provider…
Loading provider…
Surgery Physician in Winston Salem, NC
NPI: 1275518334Primary Practice Location
NORTH CAROLINA BAPTIST HOSPITAL
Medical Center Blvd, Winston Salem, NC
Primary Employer
Wake Forest University Health Sciences
wakehealth.edu
HQ Phone
Get MD Edward's Phone NumberMobile
Get MD Edward's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 97 | 117 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 42 | 42 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 29 | 37 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 19 | 19 |
| 5 | 19301Partial removal of breast | 11 | 11 |
Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations.
Authors: Carmen Solorzano, Vance Sohn, George Chang, Anthony Yang, Aimee Crago, Sam Yoon, David Bartlett, Eleftherios Mamounas, Nipun Merchant, Melissa Hogg, Giorgos Karakousis, Ajay Maker
Journal: Ann Surg Oncol
Publication Date: 2020-04-08
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Authors: Paul Sugarbaker, Armando Sardi
Publication Date: 2012-05-23
Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).
Authors: Katharine Duckworth, Richard Mcquellon, Gregory Russell, Craig Cashwell, Perry Shen, John Stewart, Edward Levine
Publication Date: 2011-11-14
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis
Lead Sponsor: Dan Blazer III, M.D.
Intervention / Treatment: BIOLOGICAL: Talimogene Laherparepvec
Lead Sponsor: OncoNano Medicine, Inc.
Intervention / Treatment: DRUG: pegsitacianine